KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Interest Expenses (2016 - 2017)

Teva Pharmaceutical Industries filings provide 9 years of Interest Expenses readings, the most recent being -$703999.1 billion for Q4 2017.

  • On a quarterly basis, Interest Expenses fell 90604877.99% to -$703999.1 billion in Q4 2017 year-over-year; TTM through Sep 2018 was -$703999.1 billion, a 241.65% decrease, with the full-year FY2017 number at $875.0 million, up 60.26% from a year prior.
  • Interest Expenses hit -$703999.1 billion in Q4 2017 for Teva Pharmaceutical Industries, down from $259000.0 billion in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $259000.0 billion in Q3 2017 to a low of -$703999.1 billion in Q4 2017.
  • Median Interest Expenses over the past 5 years was $132.0 million (2013), compared with a mean of $2400.2 billion.
  • Biggest five-year swings in Interest Expenses: surged 256097460.98% in 2016 and later crashed 90604877.99% in 2017.
  • Teva Pharmaceutical Industries' Interest Expenses stood at $59.0 million in 2013, then grew by 18.64% to $70.0 million in 2014, then changed by 0.0% to $70.0 million in 2015, then soared by 1010.0% to $777.0 million in 2016, then crashed by 90604877.99% to -$703999.1 billion in 2017.
  • The last three reported values for Interest Expenses were -$703999.1 billion (Q4 2017), $259000.0 billion (Q3 2017), and $238000.0 billion (Q2 2017) per Business Quant data.